amifostine anhydrous has been researched along with Hypertrophy in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jordan, SW | 1 |
| Yuhas, JM | 1 |
| Glick, J | 1 |
1 other study available for amifostine anhydrous and Hypertrophy
| Article | Year |
|---|---|
Modulation of cis-platinum renal toxicity by the radioprotective agent WR 2721.
Topics: Amifostine; Animals; Blood Urea Nitrogen; Cell Nucleus; Cisplatin; Female; Hypertrophy; Kidney; Kidn | 1982 |